Firm Record

Novocol Pharmaceutical of Canada Inc. findings history

39 findings from 6 inspection documents published by regulators. Each row below says what its date means.

Health Canada 2021-11-08 ~ 2025-12-02 6 documents 39 findings

Areas cited

Other quality systemAseptic processing and sterility assuranceEquipment and facilityLaboratory and QC controlsContamination controlValidation and qualificationMaterial and supplier controlDeviation, CAPA, and investigationComputer system validationStability and storage

Published inspection documents

2025-12-02 Health Canada 8 findingsOther quality system · Computer system validation · Equipment and facility · Aseptic processing and sterility assurance Water treatment plants and distribution systems were not designed, constructed, or maintained to ensure a reliable and adequate source of water. 2024-11-12 Health Canada 6 findingsEquipment and facility · Aseptic processing and sterility assurance · Validation and qualification · Computer system validation The equipment was not set-up, designed, operated, stored, and/or maintained to prevent potential contamination of drugs by other drugs and/or by foreign material. 2023-10-26 Health Canada 5 findingsLaboratory and QC controls · Deviation, CAPA, and investigation · Contamination control · Material and supplier control The validation of test methods was inadequate. 2023-10-23 Health Canada 7 findingsContamination control · Equipment and facility · Aseptic processing and sterility assurance · Laboratory and QC controls · Other quality system The sanitation programs were not adequately designed to identify and/or reduce the risks of contamination. 2023-05-23 Health Canada 3 findingsOther quality system · Validation and qualification · Contamination control The master production documents were inadequate. 2021-11-08 Health Canada 10 findingsOther quality system · Laboratory and QC controls · Equipment and facility · Aseptic processing and sterility assurance · Material and supplier control · Deviation, CAPA, and investigation · Stability and storage The controls were inadequate for creating, modifying, reviewing, storing, and/or retrieving records.

About this page

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

What is included. As of 2026-09-03, only documents that have a detail page (at least 3 findings) are listed. The company may have more documents; the full set is available in Company lookup below.

Companies are grouped by a normalised key, not the displayed name — “… Limited” and “… Ltd.” count as the same company. Translation and classification are automated and may differ in nuance from the source; the basis for judgement is always the regulator's published document.

Full history of Novocol Pharmaceutical of Canada Inc. — including inspection classifications Browse by document Go to Findings search